51
Participants
Start Date
March 13, 2020
Primary Completion Date
February 16, 2023
Study Completion Date
February 16, 2023
Moscow State budget healthcare /ID# 218569, Moscow
Russian Research Institute of Hematology and Transfusiology of the FMBA /ID# 229812, Saint Petersburg
R.M.Gorbacheva Research Institute of Paediatric Oncology, Haematology and Transp /ID# 224831, Saint Petersburg
Almazov National Medical Research Centre /ID# 218571, Saint Petersburg
Hematology department State budgetary health care institution Volgograd region /ID# 229813, Volgograd
Saratov State Medical University n.a. V.I. Razumovskiy /ID# 226059, Saratov
Clinical Medico-Sanitary Unit #1 /ID# 222502, Perm
Regional Clinical Hospital of Irkutsk /ID# 218570, Irkutsk
Republican Hospital #1 - National Center of Medicine of Sakha (Yakutia) /ID# 224830, Yakutsk
Sakhalin Regional Clinical Hospital /ID# 222501, Yuzhno-Sakhalinsk
Lead Sponsor
AbbVie
INDUSTRY